LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
Down 13% from its year high at £116.50 now, AstraZeneca’s share price looks cheap to me anywhere under £219.81
Dividend Shares
2 retirement shares that long-term investors should consider for steady income
Investing Articles
Here’s why AstraZeneca stock jumped nearly 6% in the FTSE 100 today
Investing Articles
The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?
Investing Articles
I asked ChatGPT to build the perfect Stocks and Shares ISA – and here it is!
Growth Shares
2 FTSE stocks that could do well with the DeepSeek AI breakthrough
Investing Articles
3 key reasons why AstraZeneca’s share price looks a steal to me right now
Investing Articles
These are my top 3 defensive shares to buy in 2025!
Investing Articles
FTSE shares in 2025: an opportunity to get rich?
Investing Articles
I asked ChatGPT for the best UK stocks for me to buy for 2025. Here are 5 names it gave me
Investing Articles
If the market shut down for 10 years, I’d be happy to hold these 2 FTSE 100 shares